Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies

J. Zhou, J. Luo, K. Wu, E. J. Yun, Payal Kapur, R. C. Pong, Y. Du, B. Wang, C. Authement, E. Hernandez, J. Yang, Guanghua Xiao, T. L. Cha, H. C. Wu, D. Wu, Vitaly Margulis, Yair Lotan, James B Brugarolas, D. He, Jer-Tsong Hsieh

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint Dive into the research topics of 'Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies'. Together they form a unique fingerprint.

Medicine & Life Sciences